Novel polyurethane-based nanoparticles of infliximab to reduce inflammation in an in-vitro intestinal epithelial barrier model
Author:
Funder
Irish Research Council
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference64 articles.
1. Effect of thermal and shear stressors on the physical properties, structural integrity and biological activity of the anti-TNF-alpha monoclonal antibody, infliximab;Alsaddique;Curr. Pharm. Biotechnol.,2016
2. Colon-targeted oral drug delivery systems: design trends and approaches;Amidon;AAPS PharmSciTech,2015
3. Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization;Assas;Clin. Exp. Immunol.,2017
4. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease;Beloqui;Int. J. Pharm.,2014
5. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation;Cader;Gut,2013
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular Architecture, Computational Exploration and Synthesis of PCL-PEG-PCL Triblock Copolymer-Based Reverse Nanomicelles: A Promising Method for Enhancing Macromolecular Delivery by Using Infliximab as a Model Protein;BioNanoScience;2024-08-24
2. Lipid- and polymer-based formulations containing TNF-α inhibitors for the treatment of inflammatory bowel diseases;Drug Discovery Today;2024-08
3. Oxidative Stress-Induced Gastrointestinal Diseases: Biology and Nanomedicines—A Review;BioChem;2024-07-29
4. Recent advances on emerging nanomaterials for diagnosis and treatment of inflammatory bowel disease;Journal of Controlled Release;2023-11
5. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy;Journal of Controlled Release;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3